Global Cancer Vaccine Market to Generate USD 13.4 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting
23 mars 2023 09h00 HE
|
Next Move Strategy Consulting
New York, March 23, 2023 (GLOBE NEWSWIRE) -- According to a report published by Next Move Strategy Consulting, the global Cancer Vaccine Market generated USD 5.75 billion in 2022 and is projected to...
Icosavax to Participate in the Upcoming Healthcare Conferences
28 févr. 2023 08h00 HE
|
Icosavax, Inc.
SEATTLE, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
Icosavax Granted FDA Fast Track Designation for IVX-A12
21 févr. 2023 08h00 HE
|
Icosavax, Inc.
SEATTLE, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
BioMed X Launches New T Cell Immunology Discovery Platform
14 févr. 2023 06h00 HE
|
BioMed X Institute (990552)
HEIDELBERG, Germany, Feb. 14, 2023 (GLOBE NEWSWIRE) -- BioMed X announced today the launch of its new immunology discovery platform that will allow for the accurate and fast identification of target...
We The Patriots USA Brings Lawsuit Against Idaho Daycare Over Refusing Vaccine Exemptions
09 févr. 2023 08h22 HE
|
We The Patriots USA, Inc.
MERIDIAN, Idaho, Feb. 09, 2023 (GLOBE NEWSWIRE) -- A lawsuit funded by the nonprofit organization We The Patriots USA was filed today in Ada County District Court by local counsel D. Colton Boyles,...
[Latest] Global Pneumococcal Vaccine Market Size/Share Worth USD 12 Billion by 2030 at a 5.34% CAGR: Growing cases of pneumonia to impact global market growth - Facts & Factors (Industrial Trends, Report, Forecast, Growth, Segmentation)
08 févr. 2023 07h17 HE
|
Facts & Factors
SAN FRANCISCO, USA, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Pneumococcal Vaccine Market Size, Share, Growth Analysis Report By Sector (Public...
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
01 févr. 2023 07h20 HE
|
GreenLight Biosciences
The Rwanda FDA has given regulatory approval to GreenLight to start a Phase I/II clinical trial of its Covid-19 vaccine candidate in Rwanda. This phase I/II clinical trial is the first step in...
Global Cattle Healthcare Market to Surpass US$ 13,500.9 Million by 2030, Says Coherent Market Insights (CMI)
24 janv. 2023 09h45 HE
|
CMI
Burlingame, Jan. 24, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global Cattle Healthcare Market is estimated to be valued at US$ 8,313.5 million in 2022 and is expected to...
Vaccinex Announces First Patient Dosed with Anti-CCR8 Antibody Licensed to Surface Oncology
09 janv. 2023 08h00 HE
|
Vaccinex, Inc.
ROCHESTER, N.Y., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative...
HilleVax Announces Executive Management Appointments and Promotions
09 janv. 2023 07h00 HE
|
HilleVax, Inc.
BOSTON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced the...